Rankings
▼
Calendar
BVS Q4 2023 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena
BVS
Bioventus Inc.
$593M
Q4 2023 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$135M
+7.6% YoY
Gross Profit
$86M
63.7% margin
Operating Income
$1M
0.9% margin
Net Income
-$6M
-4.5% margin
EPS (Diluted)
$-0.10
QoQ Revenue Growth
+12.1%
Cash Flow
Operating Cash Flow
$10M
Free Cash Flow
$10M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$811M
Total Liabilities
$590M
Stockholders' Equity
$174M
Cash & Equivalents
$37M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$135M
$126M
+7.6%
Gross Profit
$86M
$74M
+16.3%
Operating Income
$1M
-$25M
+104.6%
Net Income
-$6M
-$32M
+80.9%
Geographic Segments
UNITED STATES
$209M
89%
Non-US
$27M
11%
← FY 2023
All Quarters
Q1 2024 →